These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23756450)

  • 1. Estimated versus actual weight when dosing rt-PA in acute ischemic stroke: is there a difference?
    Graves A; VerHage A; Richlik B; Makic MB
    J Neurosci Nurs; 2013 Aug; 45(4):180-5. PubMed ID: 23756450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study.
    Messé SR; Kasner SE; Cucchiara BL; Demchuk A; Tanne D; Ouyang B; Levine SR;
    J Stroke Cerebrovasc Dis; 2011; 20(3):236-40. PubMed ID: 20656508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosing of tissue plasminogen activator often differs from 0.9 mg/kg, but does not affect the outcome.
    Aulicky P; Rabinstein A; Seet RC; Neumann J; Mikulik R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1293-7. PubMed ID: 23246191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke.
    Nogueira RG; Yoo AJ; Masrur S; Batista LM; Hakimelahi R; Hirsch JA; Schwamm LH
    J Neurointerv Surg; 2013 Jul; 5(4):298-301. PubMed ID: 22705875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey.
    Messé SR; Tanne D; Demchuk AM; Cucchiara BL; Levine SR; Kasner SE;
    J Stroke Cerebrovasc Dis; 2004; 13(1):35-40. PubMed ID: 17903947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of estimated-weight-base dose of alteplase in acute stroke treatment on clinical outcome.
    Cheng CY; Chen SH; Chen HM; Li CJ; Liu TY; Tan TY
    J Clin Neurosci; 2021 Mar; 85():101-105. PubMed ID: 33581779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.
    Deng YZ; Reeves MJ; Jacobs BS; Birbeck GL; Kothari RU; Hickenbottom SL; Mullard AJ; Wehner S; Maddox K; Majid A;
    Neurology; 2006 Feb; 66(3):306-12. PubMed ID: 16476927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis in right versus left hemispheric stroke.
    Blondin NA; Staff I; Lee N; McCullough LD
    J Stroke Cerebrovasc Dis; 2010; 19(4):269-72. PubMed ID: 20471856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
    J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator for acute ischemic stroke: calculation of dose based on estimated patient weight can increase the risk of cerebral bleeding.
    García-Pastor A; Díaz-Otero F; Funes-Molina C; Benito-Conde B; Grandes-Velasco S; Sobrino-García P; Vázquez-Alén P; Fernández-Bullido Y; Villanueva-Osorio JA; Gil-Núñez A
    J Thromb Thrombolysis; 2015 Oct; 40(3):347-52. PubMed ID: 25995103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating Weight of Patients With Acute Stroke When Dosing for Thrombolysis.
    Barrow T; Khan MS; Halse O; Bentley P; Sharma P
    Stroke; 2016 Jan; 47(1):228-31. PubMed ID: 26556826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trombolysis in acute stroke.
    Schwammenthal Y; Tsabari R; Bakon M; Orion D; Merzeliak O; Tanne D
    Isr Med Assoc J; 2006 Nov; 8(11):784-7. PubMed ID: 17180831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center.
    Silverman IE; Beland DK; Chhabra J; McCullough LD
    Conn Med; 2005; 69(10):613-20. PubMed ID: 16381108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.